1oga › Citations

A structural basis for immunodominant human T cell receptor recognition.

Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY
Nat Immunol 4 657-63 (2003)
Cited: 242 times
EuropePMC logo PMID: 12796775

Abstract

The anti-influenza CD8+ T cell response in HLA-A2-positive adults is almost exclusively directed at residues 58-66 of the virus matrix protein (MP(58-66)). V(beta)17V(alpha)10.2 T cell receptors (TCRs) containing a conserved arginine-serine-serine sequence in complementarity determining region 3 (CDR3) of the V(beta) segment dominate this response. To investigate the molecular basis of immunodominant selection in an outbred population, we have determined the crystal structure of V(beta)17V(alpha)10.2 in complex with MP(58-66)-HLA-A2 at a resolution of 1.4 A. We show that, whereas the TCR typically fits over an exposed side chain of the peptide, in this structure MP(58-66) exposes only main chain atoms. This distinctive orientation of V(beta)17V(alpha)10.2, which is almost orthogonal to the peptide-binding groove of HLA-A2, facilitates insertion of the conserved arginine in V(beta) CDR3 into a notch in the surface of MP(58-66)-HLA-A2. This previously unknown binding mode underlies the immunodominant T cell response.

Reviews - 1oga mentioned but not cited (8)

  1. The molecular basis of TCR germline bias for MHC is surprisingly simple. Garcia KC, Adams JJ, Feng D, Ely LK. Nat Immunol 10 143-147 (2009)
  2. Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Armstrong KM, Piepenbrink KH, Baker BM. Biochem J 415 183-196 (2008)
  3. TCR Recognition of Peptide-MHC-I: Rule Makers and Breakers. Szeto C, Lobos CA, Nguyen AT, Gras S. Int J Mol Sci 22 E68 (2020)
  4. Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities. Armstrong KM, Insaidoo FK, Baker BM. J Mol Recognit 21 275-287 (2008)
  5. Coevolution of T-cell receptors with MHC and non-MHC ligands. Castro CD, Luoma AM, Adams EJ. Immunol Rev 267 30-55 (2015)
  6. The versatility of the αβ T-cell antigen receptor. Bhati M, Cole DK, McCluskey J, Sewell AK, Rossjohn J. Protein Sci 23 260-272 (2014)
  7. The perception and response of T cells to a changing environment are based on the law of initial value. Huseby ES, Teixeiro E. Sci Signal 15 eabj9842 (2022)
  8. Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology. Reinherz EL, Hwang W, Lang MJ. Proc Natl Acad Sci U S A 120 e2215694120 (2023)

Articles - 1oga mentioned but not cited (51)

  1. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. Rapin N, Lund O, Bernaschi M, Castiglione F. PLoS One 5 e9862 (2010)
  2. IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Ehrenmann F, Kaas Q, Lefranc MP. Nucleic Acids Res 38 D301-7 (2010)
  3. Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Mohammed F, Cobbold M, Zarling AL, Salim M, Barrett-Wilt GA, Shabanowitz J, Hunt DF, Engelhard VH, Willcox BE. Nat Immunol 9 1236-1243 (2008)
  4. DeepTCR is a deep learning framework for revealing sequence concepts within T-cell repertoires. Sidhom JW, Larman HB, Pardoll DM, Baras AS. Nat Commun 12 1605 (2021)
  5. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Burrows SR, Chen Z, Archbold JK, Tynan FE, Beddoe T, Kjer-Nielsen L, Miles JJ, Khanna R, Moss DJ, Liu YC, Gras S, Kostenko L, Brennan RM, Clements CS, Brooks AG, Purcell AW, McCluskey J, Rossjohn J. Proc Natl Acad Sci U S A 107 10608-10613 (2010)
  6. Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral Antigens. Chen G, Yang X, Ko A, Sun X, Gao M, Zhang Y, Shi A, Mariuzza RA, Weng NP. Cell Rep 19 569-583 (2017)
  7. Human T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity. DeWitt WS, Smith A, Schoch G, Hansen JA, Matsen FA, Bradley P. Elife 7 e38358 (2018)
  8. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. Gadola SD, Koch M, Marles-Wright J, Lissin NM, Shepherd D, Matulis G, Harlos K, Villiger PM, Stuart DI, Jakobsen BK, Cerundolo V, Jones EY. J Exp Med 203 699-710 (2006)
  9. Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection. Miles JJ, Bulek AM, Cole DK, Gostick E, Schauenburg AJ, Dolton G, Venturi V, Davenport MP, Tan MP, Burrows SR, Wooldridge L, Price DA, Rizkallah PJ, Sewell AK. PLoS Pathog 6 e1001198 (2010)
  10. Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitope. Song I, Gil A, Mishra R, Ghersi D, Selin LK, Stern LJ. Nat Struct Mol Biol 24 395-406 (2017)
  11. Modeling the structure of bound peptide ligands to major histocompatibility complex. Tong JC, Tan TW, Ranganathan S. Protein Sci 13 2523-2532 (2004)
  12. Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction. Ely LK, Beddoe T, Clements CS, Matthews JM, Purcell AW, Kjer-Nielsen L, McCluskey J, Rossjohn J. Proc Natl Acad Sci U S A 103 6641-6646 (2006)
  13. How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire. Blevins SJ, Pierce BG, Singh NK, Riley TP, Wang Y, Spear TT, Nishimura MI, Weng Z, Baker BM. Proc Natl Acad Sci U S A 113 E1276-85 (2016)
  14. POPISK: T-cell reactivity prediction using support vector machines and string kernels. Tung CW, Ziehm M, Kämper A, Kohlbacher O, Ho SY. BMC Bioinformatics 12 446 (2011)
  15. Quantitative prediction of protein-protein binding affinity with a potential of mean force considering volume correction. Su Y, Zhou A, Xia X, Li W, Sun Z. Protein Sci 18 2550-2558 (2009)
  16. The αβTCR mechanosensor exploits dynamic ectodomain allostery to optimize its ligand recognition site. Hwang W, Mallis RJ, Lang MJ, Reinherz EL. Proc Natl Acad Sci U S A 117 21336-21345 (2020)
  17. T cell receptors are structures capable of initiating signaling in the absence of large conformational rearrangements. Fernandes RA, Shore DA, Vuong MT, Yu C, Zhu X, Pereira-Lopes S, Brouwer H, Fennelly JA, Jessup CM, Evans EJ, Wilson IA, Davis SJ. J Biol Chem 287 13324-13335 (2012)
  18. pDOCK: a new technique for rapid and accurate docking of peptide ligands to Major Histocompatibility Complexes. Khan JM, Ranganathan S. Immunome Res 6 Suppl 1 S2 (2010)
  19. Multiple glycines in TCR alpha-chains determine clonally diverse nature of human T cell memory to influenza A virus. Naumov YN, Naumova EN, Yassai MB, Kota K, Welsh RM, Selin LK. J Immunol 181 7407-7419 (2008)
  20. Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions. Luo H, Du T, Zhou P, Yang L, Mei H, Ng H, Zhang W, Shu M, Tong W, Shi L, Mendrick DL, Hong H. Comb Chem High Throughput Screen 18 296-304 (2015)
  21. Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms. Stewart-Jones GB, Simpson P, van der Merwe PA, Easterbrook P, McMichael AJ, Rowland-Jones SL, Jones EY, Gillespie GM. Proc Natl Acad Sci U S A 109 E3483-92 (2012)
  22. Exchange catalysis by tapasin exploits conserved and allele-specific features of MHC-I molecules. Lan H, Abualrous ET, Sticht J, Fernandez LMA, Werk T, Weise C, Ballaschk M, Schmieder P, Loll B, Freund C. Nat Commun 12 4236 (2021)
  23. Rational design of T cell receptors with enhanced sensitivity for antigen. Alli R, Zhang ZM, Nguyen P, Zheng JJ, Geiger TL. PLoS One 6 e18027 (2011)
  24. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope. Yang X, Chen G, Weng NP, Mariuzza RA. J Biol Chem 292 18618-18627 (2017)
  25. TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires. Leimgruber A, Ferber M, Irving M, Hussain-Kahn H, Wieckowski S, Derré L, Rufer N, Zoete V, Michielin O. PLoS One 6 e26301 (2011)
  26. Molecular design of the γδT cell receptor ectodomain encodes biologically fit ligand recognition in the absence of mechanosensing. Mallis RJ, Duke-Cohan JS, Das DK, Akitsu A, Luoma AM, Banik D, Stephens HM, Tetteh PW, Castro CD, Krahnke S, Hussey RE, Lawney B, Brazin KN, Reche PA, Hwang W, Adams EJ, Lang MJ, Reinherz EL. Proc Natl Acad Sci U S A 118 e2023050118 (2021)
  27. Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics. Jain R, Jain A, Verma SK. Int J Pept Res Ther 27 1729-1740 (2021)
  28. The contribution of major histocompatibility complex contacts to the affinity and kinetics of T cell receptor binding. Zhang H, Lim HS, Knapp B, Deane CM, Aleksic M, Dushek O, van der Merwe PA. Sci Rep 6 35326 (2016)
  29. CD8+ T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress. Zhang Y, Wu Y, Deng M, Xu D, Li X, Xu Z, Hu J, Zhang H, Liu K, Zhao Y, Gao F, Bi S, Gao GF, Zhao J, Liu WJ, Meng S. J Virol 92 e02120-17 (2018)
  30. MHC binding affects the dynamics of different T-cell receptors in different ways. Knapp B, van der Merwe PA, Dushek O, Deane CM. PLoS Comput Biol 15 e1007338 (2019)
  31. An alternative conformation of the T-cell receptor alpha constant region. van Boxel GI, Holmes S, Fugger L, Jones EY. J Mol Biol 400 828-837 (2010)
  32. Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function. Liao WW, Arthur JW. PLoS One 6 e25055 (2011)
  33. DeepAIR: A deep learning framework for effective integration of sequence and 3D structure to enable adaptive immune receptor analysis. Zhao Y, He B, Xu F, Li C, Xu Z, Su X, He H, Huang Y, Rossjohn J, Song J, Yao J. Sci Adv 9 eabo5128 (2023)
  34. DynaDom: structure-based prediction of T cell receptor inter-domain and T cell receptor-peptide-MHC (class I) association angles. Hoffmann T, Marion A, Antes I. BMC Struct Biol 17 2 (2017)
  35. Repertoire-scale measures of antigen binding. Arora R, Arnaout R. Proc Natl Acad Sci U S A 119 e2203505119 (2022)
  36. Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction. Simpson AA, Mohammed F, Salim M, Tranter A, Rickinson AB, Stauss HJ, Moss PA, Steven NM, Willcox BE. Proc Natl Acad Sci U S A 108 21176-21181 (2011)
  37. T-cell receptors binding orientation over peptide/MHC class I is driven by long-range interactions. Ferber M, Zoete V, Michielin O. PLoS One 7 e51943 (2012)
  38. Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide. Li X, Singh NK, Collins DR, Ng R, Zhang A, Lamothe-Molina PA, Shahinian P, Xu S, Tan K, Piechocka-Trocha A, Urbach JM, Weber JK, Gaiha GD, Takou Mbah OC, Huynh T, Cheever S, Chen J, Birnbaum M, Zhou R, Walker BD, Wang JH. Nat Commun 14 2929 (2023)
  39. Quantitative Analysis of the Association Angle between T-cell Receptor Vα/Vβ Domains Reveals Important Features for Epitope Recognition. Hoffmann T, Krackhardt AM, Antes I. PLoS Comput Biol 11 e1004244 (2015)
  40. SwarmTCR: a computational approach to predict the specificity of T cell receptors. Ehrlich R, Kamga L, Gil A, Luzuriaga K, Selin LK, Ghersi D. BMC Bioinformatics 22 422 (2021)
  41. Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor. Rühl G, Niedl AG, Patronov A, Siewert K, Pinkert S, Kalemanov M, Friese MA, Attfield KE, Antes I, Hohlfeld R, Dornmair K. Neurol Neuroimmunol Neuroinflamm 3 e241 (2016)
  42. Molecular mechanism of phosphopeptide neoantigen immunogenicity. Patskovsky Y, Natarajan A, Patskovska L, Nyovanie S, Joshi B, Morin B, Brittsan C, Huber O, Gordon S, Michelet X, Schmitzberger F, Stein RB, Findeis MA, Hurwitz A, Van Dijk M, Chantzoura E, Yague AS, Pollack Smith D, Buell JS, Underwood D, Krogsgaard M. Nat Commun 14 3763 (2023)
  43. Revisiting the putative TCR Cα dimerization model through structural analysis. Wang JH, Reinherz EL. Front Immunol 4 16 (2013)
  44. Development of immune-specific interaction potentials and their application in the multi-agent-system VaccImm. Woelke AL, von Eichborn J, Murgueitio MS, Worth CL, Castiglione F, Preissner R. PLoS One 6 e23257 (2011)
  45. A Leucine Zipper Dimerization Strategy to Generate Soluble T Cell Receptors Using the Escherichia coli Expression System. Zhang A, Piechocka-Trocha A, Li X, Walker BD. Cells 11 312 (2022)
  46. An integrated approach to the characterization of immune repertoires using AIMS: An Automated Immune Molecule Separator. Boughter CT, Meier-Schellersheim M. PLoS Comput Biol 19 e1011577 (2023)
  47. Dynamic kernel matching for non-conforming data: A case study of T cell receptor datasets. Ostmeyer J, Cowell L, Christley S. PLoS One 18 e0265313 (2023)
  48. Large-scale template-based structural modeling of T-cell receptors with known antigen specificity reveals complementarity features. Shcherbinin DS, Karnaukhov VK, Zvyagin IV, Chudakov DM, Shugay M. Front Immunol 14 1224969 (2023)
  49. Non-Antigenic Modulation of Antigen Receptor (TCR) Cβ-FG Loop Modulates Signalling: Implications of External Factors Influencing T-Cell Responses. Manolios N, Pham S, Hou G, Du J, Quek C, Hibbs D. Int J Mol Sci 24 9334 (2023)
  50. Structural and Mechanistic Implications of Rearrangement Frequencies within Human TCRBV Genes. Yassai MB, Demos W, Gorski J. J Immunol 199 1142-1152 (2017)
  51. The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific. Ahn YM, Maddumage JC, Grant EJ, Chatzileontiadou DSM, Perera WWJG, Baker BM, Szeto C, Gras S. Curr Res Struct Biol 7 100148 (2024)


Reviews citing this publication (41)

  1. How TCRs bind MHCs, peptides, and coreceptors. Rudolph MG, Stanfield RL, Wilson IA. Annu Rev Immunol 24 419-466 (2006)
  2. T cell antigen receptor recognition of antigen-presenting molecules. Rossjohn J, Gras S, Miles JJ, Turner SJ, Godfrey DI, McCluskey J. Annu Rev Immunol 33 169-200 (2015)
  3. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Yewdell JW. Immunity 25 533-543 (2006)
  4. Structural determinants of T-cell receptor bias in immunity. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Nat Rev Immunol 6 883-894 (2006)
  5. Harnessing invariant NKT cells in vaccination strategies. Cerundolo V, Silk JD, Masri SH, Salio M. Nat Rev Immunol 9 28-38 (2009)
  6. The molecular basis for public T-cell responses? Venturi V, Price DA, Douek DC, Davenport MP. Nat Rev Immunol 8 231-238 (2008)
  7. Evolutionarily conserved amino acids that control TCR-MHC interaction. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW. Annu Rev Immunol 26 171-203 (2008)
  8. Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination. Miles JJ, Douek DC, Price DA. Immunol Cell Biol 89 375-387 (2011)
  9. How T cells 'see' antigen. Krogsgaard M, Davis MM. Nat Immunol 6 239-245 (2005)
  10. Understanding the drivers of MHC restriction of T cell receptors. La Gruta NL, Gras S, Daley SR, Thomas PG, Rossjohn J. Nat Rev Immunol 18 467-478 (2018)
  11. Immunoglobulin superfamily cell adhesion molecules: zippers and signals. Aricescu AR, Jones EY. Curr Opin Cell Biol 19 543-550 (2007)
  12. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Godfrey DI, Rossjohn J, McCluskey J. Immunity 28 304-314 (2008)
  13. A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, Rossjohn J. Immunol Rev 250 61-81 (2012)
  14. T-cell receptor bias and immunity. Gras S, Kjer-Nielsen L, Burrows SR, McCluskey J, Rossjohn J. Curr Opin Immunol 20 119-125 (2008)
  15. Immunity to seasonal and pandemic influenza A viruses. Valkenburg SA, Rutigliano JA, Ellebedy AH, Doherty PC, Thomas PG, Kedzierska K. Microbes Infect 13 489-501 (2011)
  16. Establishment and recall of CD8+ T-cell memory in a model of localized transient infection. Kedzierska K, La Gruta NL, Turner SJ, Doherty PC. Immunol Rev 211 133-145 (2006)
  17. Structural and functional aspects of lipid binding by CD1 molecules. Silk JD, Salio M, Brown J, Jones EY, Cerundolo V. Annu Rev Cell Dev Biol 24 369-395 (2008)
  18. Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. Deng L, Mariuzza RA. Trends Biochem Sci 32 500-508 (2007)
  19. Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity. Kedzierska K, La Gruta NL, Stambas J, Turner SJ, Doherty PC. Mol Immunol 45 607-618 (2008)
  20. Specificity on a knife-edge: the alphabeta T cell receptor. Clements CS, Dunstone MA, Macdonald WA, McCluskey J, Rossjohn J. Curr Opin Struct Biol 16 787-795 (2006)
  21. Unusual features of self-peptide/MHC binding by autoimmune T cell receptors. Nicholson MJ, Hahn M, Wucherpfennig KW. Immunity 23 351-360 (2005)
  22. Understanding the complexity and malleability of T-cell recognition. Miles JJ, McCluskey J, Rossjohn J, Gras S. Immunol Cell Biol 93 433-441 (2015)
  23. Understanding the structural dynamics of TCR-pMHC complex interactions. Kass I, Buckle AM, Borg NA. Trends Immunol 35 604-612 (2014)
  24. Characterization of CD8+ T cell repertoire diversity and persistence in the influenza A virus model of localized, transient infection. Turner SJ, Kedzierska K, La Gruta NL, Webby R, Doherty PC. Semin Immunol 16 179-184 (2004)
  25. TCR-MHC docking orientation: natural selection, or thymic selection? Collins EJ, Riddle DS. Immunol Res 41 267-294 (2008)
  26. T-large granular lymphocyte leukemia: current molecular concepts. Wlodarski MW, Schade AE, Maciejewski JP. Hematology 11 245-256 (2006)
  27. CD8 T cell responses to viral infections in sequence. Brehm MA, Selin LK, Welsh RM. Cell Microbiol 6 411-421 (2004)
  28. T cell allorecognition and MHC restriction--A case of Jekyll and Hyde? Archbold JK, Ely LK, Kjer-Nielsen L, Burrows SR, Rossjohn J, McCluskey J, Macdonald WA. Mol Immunol 45 583-598 (2008)
  29. Allopeptides and the alloimmune response. Bharat A, Mohanakumar T. Cell Immunol 248 31-43 (2007)
  30. T cell receptor specificity for major histocompatibility complex proteins. Marrack P, Rubtsova K, Scott-Browne J, Kappler JW. Curr Opin Immunol 20 203-207 (2008)
  31. Autoreactive T cells in human type 1 diabetes. Tree TI, Peakman M. Endocrinol Metab Clin North Am 33 113-33, ix-x (2004)
  32. αβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapy. Reinherz EL. Cancer Immunol Res 3 305-312 (2015)
  33. Molecular tracking of antigen-specific T-cell clones during immune responses. Rufer N. Curr Opin Immunol 17 441-447 (2005)
  34. Antigen-driven T-cell repertoire selection during adaptive immune responses. Baumgartner CK, Malherbe LP. Immunol Cell Biol 89 54-59 (2011)
  35. The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease. Kedzierska K, Koutsakos M. Viral Immunol 33 160-178 (2020)
  36. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine. Fox A, Quinn KM, Subbarao K. Drugs 78 1297-1308 (2018)
  37. Some lessons from the systematic production and structural analysis of soluble (alpha)(beta) T-cell receptors. van Boxel GI, Stewart-Jones G, Holmes S, Sainsbury S, Shepherd D, Gillespie GM, Harlos K, Stuart DI, Owens R, Jones EY. J Immunol Methods 350 14-21 (2009)
  38. How age and infection history shape the antigen-specific CD8+ T-cell repertoire: Implications for vaccination strategies in older adults. Lanfermeijer J, Borghans JAM, van Baarle D. Aging Cell 19 e13262 (2020)
  39. Forward Vaccinology: CTL Targeting Based upon Physical Detection of HLA-Bound Peptides. Reinherz EL, Keskin DB, Reinhold B. Front Immunol 5 418 (2014)
  40. Legacy of the influenza pandemic 1918: The host T cell response. McMichael AJ. Biomed J 41 242-248 (2018)
  41. Stereo electronic principles for selecting fully-protective, chemically-synthesised malaria vaccines. Patarroyo ME, Bermudez A, Alba MP, Patarroyo MA, Suarez C, Aza-Conde J, Moreno-Vranich A, Vanegas M. Front Immunol 13 926680 (2022)

Articles citing this publication (142)

  1. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Dash P, Fiore-Gartland AJ, Hertz T, Wang GC, Sharma S, Souquette A, Crawford JC, Clemens EB, Nguyen THO, Kedzierska K, La Gruta NL, Bradley P, Thomas PG. Nature 547 89-93 (2017)
  2. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, Roederer M, Koup RA, Migueles SA, Gostick E, Wooldridge L, Sewell AK, Connors M, Douek DC. J Exp Med 202 1349-1361 (2005)
  3. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Price DA, West SM, Betts MR, Ruff LE, Brenchley JM, Ambrozak DR, Edghill-Smith Y, Kuroda MJ, Bogdan D, Kunstman K, Letvin NL, Franchini G, Wolinsky SM, Koup RA, Douek DC. Immunity 21 793-803 (2004)
  4. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J. Nat Immunol 6 1114-1122 (2005)
  5. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Hahn M, Nicholson MJ, Pyrdol J, Wucherpfennig KW. Nat Immunol 6 490-496 (2005)
  6. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, van der Merwe PA, Jakobsen BK, Griffiths G, Jones EY, Cerundolo V. J Exp Med 201 1243-1255 (2005)
  7. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Krogsgaard M, Prado N, Adams EJ, He XL, Chow DC, Wilson DB, Garcia KC, Davis MM. Mol Cell 12 1367-1378 (2003)
  8. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Tynan FE, Reid HH, Kjer-Nielsen L, Miles JJ, Wilce MC, Kostenko L, Borg NA, Williamson NA, Beddoe T, Purcell AW, Burrows SR, McCluskey J, Rossjohn J. Nat Immunol 8 268-276 (2007)
  9. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. Li Y, Huang Y, Lue J, Quandt JA, Martin R, Mariuzza RA. EMBO J 24 2968-2979 (2005)
  10. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Borg NA, Ely LK, Beddoe T, Macdonald WA, Reid HH, Clements CS, Purcell AW, Kjer-Nielsen L, Miles JJ, Burrows SR, McCluskey J, Rossjohn J. Nat Immunol 6 171-180 (2005)
  11. Crossreactive T Cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules. Dai S, Huseby ES, Rubtsova K, Scott-Browne J, Crawford F, Macdonald WA, Marrack P, Kappler JW. Immunity 28 324-334 (2008)
  12. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. Cole DK, Yuan F, Rizkallah PJ, Miles JJ, Gostick E, Price DA, Gao GF, Jakobsen BK, Sewell AK. J Biol Chem 284 27281-27289 (2009)
  13. T cell cross-reactivity and conformational changes during TCR engagement. Lee JK, Stewart-Jones G, Dong T, Harlos K, Di Gleria K, Dorrell L, Douek DC, van der Merwe PA, Jones EY, McMichael AJ. J Exp Med 200 1455-1466 (2004)
  14. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Harkiolaki M, Holmes SL, Svendsen P, Gregersen JW, Jensen LT, McMahon R, Friese MA, van Boxel G, Etzensperger R, Tzartos JS, Kranc K, Sainsbury S, Harlos K, Mellins ED, Palace J, Esiri MM, van der Merwe PA, Jones EY, Fugger L. Immunity 30 348-357 (2009)
  15. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Kedzierska K, Turner SJ, Doherty PC. Proc Natl Acad Sci U S A 101 4942-4947 (2004)
  16. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Turner SJ, Kedzierska K, Komodromou H, La Gruta NL, Dunstone MA, Webb AI, Webby R, Walden H, Xie W, McCluskey J, Purcell AW, Rossjohn J, Doherty PC. Nat Immunol 6 382-389 (2005)
  17. Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination. Venturi V, Kedzierska K, Price DA, Doherty PC, Douek DC, Turner SJ, Davenport MP. Proc Natl Acad Sci U S A 103 18691-18696 (2006)
  18. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. Huang S, Gilfillan S, Cella M, Miley MJ, Lantz O, Lybarger L, Fremont DH, Hansen TH. J Biol Chem 280 21183-21193 (2005)
  19. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. Tynan FE, Borg NA, Miles JJ, Beddoe T, El-Hassen D, Silins SL, van Zuylen WJ, Purcell AW, Kjer-Nielsen L, McCluskey J, Burrows SR, Rossjohn J. J Biol Chem 280 23900-23909 (2005)
  20. CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients. Mallajosyula V, Ganjavi C, Chakraborty S, McSween AM, Pavlovitch-Bedzyk AJ, Wilhelmy J, Nau A, Manohar M, Nadeau KC, Davis MM. Sci Immunol 6 eabg5669 (2021)
  21. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex. Beringer DX, Beringer DX, Kleijwegt FS, Wiede F, van der Slik AR, Loh KL, Petersen J, Dudek NL, Duinkerken G, Laban S, Joosten A, Vivian JP, Chen Z, Uldrich AP, Godfrey DI, McCluskey J, Price DA, Radford KJ, Purcell AW, Nikolic T, Reid HH, Tiganis T, Roep BO, Rossjohn J. Nat Immunol 16 1153-1161 (2015)
  22. Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs. Wang H, Fang Z, Morita CT. J Immunol 184 6209-6222 (2010)
  23. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. Davis-Harrison RL, Armstrong KM, Baker BM. J Mol Biol 346 533-550 (2005)
  24. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. Kjer-Nielsen L, Borg NA, Pellicci DG, Beddoe T, Kostenko L, Clements CS, Williamson NA, Smyth MJ, Besra GS, Reid HH, Bharadwaj M, Godfrey DI, Rossjohn J, McCluskey J. J Exp Med 203 661-673 (2006)
  25. The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Ishizuka J, Stewart-Jones GB, van der Merwe A, Bell JI, McMichael AJ, Jones EY. Immunity 28 171-182 (2008)
  26. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L, Appay V, Weekes M, Conlon C, Spina C, Little S, Screaton G, van der Merwe A, Richman DD, McMichael AJ, Jones EY, Rowland-Jones SL. J Exp Med 200 1547-1557 (2004)
  27. Have we cut ourselves too short in mapping CTL epitopes? Burrows SR, Rossjohn J, McCluskey J. Trends Immunol 27 11-16 (2006)
  28. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses. Valkenburg SA, Josephs TM, Clemens EB, Grant EJ, Nguyen TH, Wang GC, Price DA, Miller A, Tong SY, Thomas PG, Doherty PC, Rossjohn J, Gras S, Kedzierska K. Proc Natl Acad Sci U S A 113 4440-4445 (2016)
  29. Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease. Wang Z, Zhu L, Nguyen THO, Wan Y, Sant S, Quiñones-Parra SM, Crawford JC, Eltahla AA, Rizzetto S, Bull RA, Qiu C, Koutsakos M, Clemens EB, Loh L, Chen T, Liu L, Cao P, Ren Y, Kedzierski L, Kotsimbos T, McCaw JM, La Gruta NL, Turner SJ, Cheng AC, Luciani F, Zhang X, Doherty PC, Thomas PG, Xu J, Kedzierska K. Nat Commun 9 824 (2018)
  30. A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. Buslepp J, Wang H, Biddison WE, Appella E, Collins EJ. Immunity 19 595-606 (2003)
  31. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. Liu J, Wu P, Gao F, Qi J, Kawana-Tachikawa A, Xie J, Vavricka CJ, Iwamoto A, Li T, Gao GF. J Virol 84 11849-11857 (2010)
  32. Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Iversen AK, Stewart-Jones G, Learn GH, Christie N, Sylvester-Hviid C, Armitage AE, Kaul R, Beattie T, Lee JK, Li Y, Chotiyarnwong P, Dong T, Xu X, Luscher MA, MacDonald K, Ullum H, Klarlund-Pedersen B, Skinhøj P, Fugger L, Buus S, Mullins JI, Jones EY, van der Merwe PA, McMichael AJ. Nat Immunol 7 179-189 (2006)
  33. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. Berkhoff EG, de Wit E, Geelhoed-Mieras MM, Boon AC, Symons J, Symons J, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. J Virol 79 11239-11246 (2005)
  34. Predicting HLA CD4 Immunogenicity in Human Populations. Dhanda SK, Karosiene E, Edwards L, Grifoni A, Paul S, Andreatta M, Weiskopf D, Sidney J, Nielsen M, Peters B, Sette A. Front Immunol 9 1369 (2018)
  35. Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Deng L, Langley RJ, Brown PH, Xu G, Teng L, Wang Q, Gonzales MI, Callender GG, Nishimura MI, Topalian SL, Mariuzza RA. Nat Immunol 8 398-408 (2007)
  36. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. Tynan FE, Elhassen D, Purcell AW, Burrows JM, Borg NA, Miles JJ, Williamson NA, Green KJ, Tellam J, Kjer-Nielsen L, McCluskey J, Rossjohn J, Burrows SR. J Exp Med 202 1249-1260 (2005)
  37. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T, Frahm N, Feeney ME, Tang Y, Pereyra F, Labute MX, Pfafferott K, Leslie A, Crawford H, Allgaier R, Hildebrand W, Kaslow R, Brander C, Allen TM, Rosenberg ES, Kiepiela P, Vajpayee M, Goepfert PA, Altfeld M, Goulder PJ, Walker BD. J Virol 81 1619-1631 (2007)
  38. Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection. Yin Y, Li Y, Kerzic MC, Martin R, Mariuzza RA. EMBO J 30 1137-1148 (2011)
  39. T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability. Riley TP, Hellman LM, Gee MH, Mendoza JL, Alonso JA, Foley KC, Nishimura MI, Vander Kooi CW, Garcia KC, Baker BM. Nat Chem Biol 14 934-942 (2018)
  40. Quantification of repertoire diversity of influenza-specific epitopes with predominant public or private TCR usage. Kedzierska K, Day EB, Pi J, Heard SB, Doherty PC, Turner SJ, Perlman S. J Immunol 177 6705-6712 (2006)
  41. A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3. Hülsmeyer M, Chames P, Hillig RC, Stanfield RL, Held G, Coulie PG, Alings C, Wille G, Saenger W, Uchanska-Ziegler B, Hoogenboom HR, Ziegler A. J Biol Chem 280 2972-2980 (2005)
  42. Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501. Probst-Kepper M, Hecht HJ, Herrmann H, Janke V, Ocklenburg F, Klempnauer J, van den Eynde BJ, Weiss S. J Immunol 173 5610-5616 (2004)
  43. CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells. Kluesner MG, Lahr WS, Lonetree CL, Smeester BA, Qiu X, Slipek NJ, Claudio Vázquez PN, Pitzen SP, Pomeroy EJ, Vignes MJ, Lee SC, Bingea SP, Andrew AA, Webber BR, Moriarity BS. Nat Commun 12 2437 (2021)
  44. Single-Cell Approach to Influenza-Specific CD8+ T Cell Receptor Repertoires Across Different Age Groups, Tissues, and Following Influenza Virus Infection. Sant S, Grzelak L, Wang Z, Pizzolla A, Koutsakos M, Crowe J, Loudovaris T, Mannering SI, Westall GP, Wakim LM, Rossjohn J, Gras S, Richards M, Xu J, Thomas PG, Loh L, Nguyen THO, Kedzierska K. Front Immunol 9 1453 (2018)
  45. Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires. Salerno-Gonçalves R, Wahid R, Sztein MB. Infect Immun 73 3521-3530 (2005)
  46. The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection. Chaves FA, Lee AH, Nayak JL, Richards KA, Sant AJ. J Immunol 188 4235-4248 (2012)
  47. Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides. Siewert K, Malotka J, Kawakami N, Wekerle H, Hohlfeld R, Dornmair K. Nat Med 18 824-828 (2012)
  48. Ecological analysis of antigen-specific CTL repertoires defines the relationship between naive and immune T-cell populations. Thomas PG, Handel A, Doherty PC, La Gruta NL. Proc Natl Acad Sci U S A 110 1839-1844 (2013)
  49. The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation. Saline M, Rödström KE, Fischer G, Orekhov VY, Karlsson BG, Lindkvist-Petersson K. Nat Commun 1 119 (2010)
  50. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Wynn KK, Fulton Z, Cooper L, Silins SL, Gras S, Archbold JK, Tynan FE, Miles JJ, McCluskey J, Burrows SR, Rossjohn J, Khanna R. Blood 111 4283-4292 (2008)
  51. Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations. Chu HH, Moon JJ, Kruse AC, Pepper M, Jenkins MK. J Immunol 185 4705-4713 (2010)
  52. Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes. Fazakerley DJ, Naghiloo S, Chaudhuri R, Koumanov F, Burchfield JG, Thomas KC, Krycer JR, Prior MJ, Parker BL, Murrow BA, Stöckli J, Meoli CC, Holman GD, James DE. J Biol Chem 290 23528-23542 (2015)
  53. Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses. Sun Y, Liu J, Yang M, Gao F, Zhou J, Kitamura Y, Gao B, Tien P, Shu Y, Iwamoto A, Chen Z, Gao GF. J Gen Virol 91 919-930 (2010)
  54. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance. Meijers R, Lai CC, Yang Y, Liu JH, Zhong W, Wang JH, Reinherz EL. J Mol Biol 345 1099-1110 (2005)
  55. A modified ABCDE model of flowering in orchids based on gene expression profiling studies of the moth orchid Phalaenopsis aphrodite. Su CL, Chen WC, Lee AY, Chen CY, Chang YC, Chao YT, Shih MC. PLoS One 8 e80462 (2013)
  56. Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide. Chan KF, Gully BS, Gras S, Beringer DX, Kjer-Nielsen L, Cebon J, McCluskey J, Chen W, Rossjohn J. Nat Commun 9 1026 (2018)
  57. Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8+ T-cell responses. Day EB, Guillonneau C, Gras S, La Gruta NL, Vignali DA, Doherty PC, Purcell AW, Rossjohn J, Turner SJ. Proc Natl Acad Sci U S A 108 9536-9541 (2011)
  58. Structure of the superantigen staphylococcal enterotoxin B in complex with TCR and peptide-MHC demonstrates absence of TCR-peptide contacts. Rödström KE, Elbing K, Lindkvist-Petersson K. J Immunol 193 1998-2004 (2014)
  59. Naive CD8⁺ T-cell precursors display structured TCR repertoires and composite antigen-driven selection dynamics. Neller MA, Ladell K, McLaren JE, Matthews KK, Gostick E, Pentier JM, Dolton G, Schauenburg AJ, Koning D, Fontaine Costa AI, Watkins TS, Venturi V, Smith C, Khanna R, Miners K, Clement M, Wooldridge L, Cole DK, van Baarle D, Sewell AK, Burrows SR, Price DA, Miles JJ. Immunol Cell Biol 93 625-633 (2015)
  60. Reproducible selection of high avidity CD8+ T-cell clones following secondary acute virus infection. Cukalac T, Chadderton J, Handel A, Doherty PC, Turner SJ, Thomas PG, La Gruta NL. Proc Natl Acad Sci U S A 111 1485-1490 (2014)
  61. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants. Gagnon SJ, Borbulevych OY, Davis-Harrison RL, Baxter TK, Clemens JR, Armstrong KM, Turner RV, Damirjian M, Biddison WE, Baker BM. J Mol Biol 353 556-573 (2005)
  62. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. Patel O, Pellicci DG, Uldrich AP, Sullivan LC, Bhati M, McKnight M, Richardson SK, Howell AR, Mallevaey T, Zhang J, Bedel R, Besra GS, Brooks AG, Kjer-Nielsen L, McCluskey J, Porcelli SA, Gapin L, Rossjohn J, Godfrey DI. Proc Natl Acad Sci U S A 108 19007-19012 (2011)
  63. CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals. Crompton L, Khan N, Khanna R, Nayak L, Moss PA. Blood 111 2053-2061 (2008)
  64. Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations. Liu J, Wu B, Zhang S, Tan S, Sun Y, Chen Z, Qin Y, Sun M, Shi G, Wu Y, Sun M, Liu N, Ning K, Ma Y, Gao B, Yan J, Zhu F, Wang H, Gao GF. Eur J Immunol 43 2055-2069 (2013)
  65. Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection. Shimizu A, Kawana-Tachikawa A, Yamagata A, Han C, Zhu D, Sato Y, Nakamura H, Koibuchi T, Carlson J, Martin E, Brumme CJ, Shi Y, Gao GF, Brumme ZL, Fukai S, Iwamoto A. Sci Rep 3 3097 (2013)
  66. Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues. Derré L, Bruyninx M, Baumgaertner P, Ferber M, Schmid D, Leimgruber A, Zoete V, Romero P, Michielin O, Speiser DE, Rufer N. Proc Natl Acad Sci U S A 105 15010-15015 (2008)
  67. TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. Ahmed M, Lopez-Albaitero A, Pankov D, Santich BH, Liu H, Yan S, Xiang J, Wang P, Hasan AN, Selvakumar A, O'Reilly RJ, Liu C, Cheung NV. JCI Insight 3 97805 (2018)
  68. Increased Peptide Contacts Govern High Affinity Binding of a Modified TCR Whilst Maintaining a Native pMHC Docking Mode. Cole DK, Sami M, Scott DR, Rizkallah PJ, Borbulevych OY, Todorov PT, Moysey RK, Jakobsen BK, Boulter JM, Baker BM, Yi Li. Front Immunol 4 168 (2013)
  69. Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope. Yang X, Gao M, Chen G, Pierce BG, Lu J, Weng NP, Mariuzza RA. J Biol Chem 290 29106-29119 (2015)
  70. T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection. Billam P, Bonaparte KL, Liu J, Ruckwardt TJ, Chen M, Ryder AB, Wang R, Dash P, Thomas PG, Graham BS. J Biol Chem 286 4829-4841 (2011)
  71. Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy. Zhang C, Peng Y, Hublitz P, Zhang H, Dong T. Sci Rep 8 5549 (2018)
  72. TCR/pMHC Optimized Protein crystallization Screen. Bulek AM, Madura F, Fuller A, Holland CJ, Schauenburg AJ, Sewell AK, Rizkallah PJ, Cole DK. J Immunol Methods 382 203-210 (2012)
  73. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells. Lee MN, Meyerson M. Sci Immunol 6 eabf4001 (2021)
  74. CD8+ T cells specific for the islet autoantigen IGRP are restricted in their T cell receptor chain usage. Fuchs YF, Eugster A, Dietz S, Sebelefsky C, Kühn D, Wilhelm C, Lindner A, Gavrisan A, Knoop J, Dahl A, Ziegler AG, Bonifacio E. Sci Rep 7 44661 (2017)
  75. Accurate prediction of immunogenic T-cell epitopes from epitope sequences using the genetic algorithm-based ensemble learning. Zhang W, Niu Y, Zou H, Luo L, Liu Q, Wu W. PLoS One 10 e0128194 (2015)
  76. Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein. Varela-Calvino R, Skowera A, Arif S, Peakman M. J Virol 78 13399-13408 (2004)
  77. Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures. Grant EJ, Josephs TM, Valkenburg SA, Wooldridge L, Hellard M, Rossjohn J, Bharadwaj M, Kedzierska K, Gras S. J Biol Chem 291 24335-24351 (2016)
  78. Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes. Zhang S, Liu J, Cheng H, Tan S, Qi J, Yan J, Gao GF. Mol Immunol 49 395-401 (2011)
  79. Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimers. Holland CJ, Rizkallah PJ, Vollers S, Calvo-Calle JM, Madura F, Fuller A, Sewell AK, Stern LJ, Godkin A, Cole DK. Sci Rep 2 629 (2012)
  80. Proline substitution independently enhances H-2D(b) complex stabilization and TCR recognition of melanoma-associated peptides. Uchtenhagen H, Abualrous ET, Stahl E, Allerbring EB, Sluijter M, Zacharias M, Sandalova T, van Hall T, Springer S, Nygren PÅ, Achour A. Eur J Immunol 43 3051-3060 (2013)
  81. Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals. van den Heuvel H, Heutinck KM, van der Meer-Prins EMW, Yong SL, van Miert PPMC, Anholts JDH, Franke-van Dijk MEI, Zhang XQ, Roelen DL, Ten Berge RJM, Claas FHJ. Am J Transplant 17 2033-2044 (2017)
  82. Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex. Zhao Y, Li Z, Drozd SJ, Guo Y, Mourad W, Li H. Structure 12 277-288 (2004)
  83. Cutting edge: Evidence of direct TCR alpha-chain interaction with superantigen. Pumphrey N, Vuidepot A, Jakobsen B, Forsberg G, Walse B, Lindkvist-Petersson K. J Immunol 179 2700-2704 (2007)
  84. T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope. Wahl A, McCoy WH, Schafer F, Bardet W, Buchli R, Fremont DH, Hildebrand WH. J Virol 83 9206-9214 (2009)
  85. Terminal deoxynucleotidyltransferase is required for the establishment of private virus-specific CD8+ TCR repertoires and facilitates optimal CTL responses. Kedzierska K, Thomas PG, Venturi V, Davenport MP, Doherty PC, Turner SJ, La Gruta NL. J Immunol 181 2556-2562 (2008)
  86. Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans. Reiser JB, Legoux F, Gras S, Trudel E, Chouquet A, Léger A, Le Gorrec M, Machillot P, Bonneville M, Saulquin X, Housset D. J Immunol 193 5816-5826 (2014)
  87. Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase. Touvrey C, Derré L, Devevre E, Corthesy P, Romero P, Rufer N, Speiser DE. J Immunol 182 6718-6726 (2009)
  88. Fixing an irrelevant TCR alpha chain reveals the importance of TCR beta diversity for optimal TCR alpha beta pairing and function of virus-specific CD8+ T cells. Valkenburg SA, Day EB, Swan NG, Croom HA, Carbone FR, Doherty PC, Turner SJ, Kedzierska K. Eur J Immunol 40 2470-2481 (2010)
  89. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen. Rosloniec EF, Ivey RA, Whittington KB, Kang AH, Park HW. J Immunol 177 3884-3892 (2006)
  90. Methods for quantifying T cell receptor binding affinities and thermodynamics. Piepenbrink KH, Gloor BE, Armstrong KM, Baker BM. Methods Enzymol 466 359-381 (2009)
  91. Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry. Miles JJ, Tan MP, Dolton G, Edwards ES, Galloway SA, Laugel B, Clement M, Makinde J, Ladell K, Matthews KK, Watkins TS, Tungatt K, Wong Y, Lee HS, Clark RJ, Pentier JM, Attaf M, Lissina A, Ager A, Gallimore A, Rizkallah PJ, Gras S, Rossjohn J, Burrows SR, Cole DK, Price DA, Sewell AK. J Clin Invest 128 1569-1580 (2018)
  92. Superimposed epitopes restricted by the same HLA molecule drive distinct HIV-specific CD8+ T cell repertoires. Sun X, Fujiwara M, Shi Y, Kuse N, Gatanaga H, Appay V, Gao GF, Oka S, Takiguchi M. J Immunol 193 77-84 (2014)
  93. PAAQD: Predicting immunogenicity of MHC class I binding peptides using amino acid pairwise contact potentials and quantum topological molecular similarity descriptors. Saethang T, Hirose O, Kimkong I, Tran VA, Dang XT, Nguyen LA, Le TK, Kubo M, Yamada Y, Satou K. J Immunol Methods 387 293-302 (2013)
  94. Rapid detection of clonal expansion of T-cell receptor-beta gene in patients with HBV using the real-time PCR with DNA melting curve analysis. Yang JZ, Li MW, Wang JG, Lu HF, Yao XS, He JQ, Li LJ. Hepatol Res 40 407-414 (2010)
  95. Selective T cell expansion during aging of CD8 memory repertoires to influenza revealed by modeling. Naumov YN, Naumova EN, Yassai MB, Gorski J. J Immunol 186 6617-6624 (2011)
  96. Comment The problem of plain vanilla peptides. Davis MM. Nat Immunol 4 649-650 (2003)
  97. Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens. Park MS, Park SY, Miller KR, Collins EJ, Lee HY. Mol Immunol 56 81-90 (2013)
  98. The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants. Petrova GV, Naumova EN, Gorski J. J Immunol 186 6390-6397 (2011)
  99. An extensive antigenic footprint underpins immunodominant TCR adaptability against a hypervariable viral determinant. Nivarthi UK, Gras S, Kjer-Nielsen L, Berry R, Lucet IS, Miles JJ, Tracy SL, Purcell AW, Bowden DS, Hellard M, Rossjohn J, McCluskey J, Bharadwaj M. J Immunol 193 5402-5413 (2014)
  100. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice. Hu N, D'Souza C, Cheung H, Lang H, Cheuk E, Chamberlain JW. Vaccine 23 5231-5244 (2005)
  101. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy. Bai P, Li Y, Zhou Q, Xia J, Wei PC, Deng H, Wu M, Chan SK, Kappler JW, Zhou Y, Tran E, Marrack P, Yin L. Oncoimmunology 10 1868130 (2021)
  102. CD4+ T Cells Recognize Conserved Influenza A Epitopes through Shared Patterns of V-Gene Usage and Complementary Biochemical Features. Greenshields-Watson A, Attaf M, MacLachlan BJ, Whalley T, Rius C, Wall A, Lloyd A, Hughes H, Strange KE, Mason GH, Schauenburg AJ, Hulin-Curtis SL, Geary J, Chen Y, Lauder SN, Smart K, Vijaykrishna D, Grau ML, Shugay M, Andrews R, Dolton G, Rizkallah PJ, Gallimore AM, Sewell AK, Godkin AJ, Cole DK. Cell Rep 32 107885 (2020)
  103. Naive T cell repertoire skewing in HLA-A2 individuals by a specialized rearrangement mechanism results in public memory clonotypes. Yassai M, Bosenko D, Unruh M, Zacharias G, Reed E, Demos W, Ferrante A, Gorski J. J Immunol 186 2970-2977 (2011)
  104. Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides. Zhu S, Liu K, Chai Y, Wu Y, Lu D, Xiao W, Cheng H, Zhao Y, Ding C, Lyu J, Lou Y, Gao GF, Liu WJ. Front Immunol 10 1709 (2019)
  105. Predictable alphabeta T-cell receptor selection toward an HLA-B*3501-restricted human cytomegalovirus epitope. Brennan RM, Miles JJ, Silins SL, Bell MJ, Burrows JM, Burrows SR. J Virol 81 7269-7273 (2007)
  106. Predicting interactions between T cell receptors and MHC-peptide complexes. Roomp K, Domingues FS. Mol Immunol 48 553-562 (2011)
  107. A highly restricted T-cell receptor dominates the CD8+ T-cell response to parvovirus B19 infection in HLA-A*2402-positive individuals. Kasprowicz V, Isa A, Jeffery K, Broliden K, Tolfvenstam T, Klenerman P, Bowness P. J Virol 80 6697-6701 (2006)
  108. Immune parameters to consider when choosing T-cell receptors for therapy. Burrows SR, Miles JJ. Front Immunol 4 229 (2013)
  109. Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes. Gibadullin R, Randall CJ, Sidney J, Sette A, Gellman SH. J Am Chem Soc 143 6470-6481 (2021)
  110. Cross-reactive responses to modified M1₅₈-₆₆ peptides by CD8⁺ T cells that use noncanonical BV genes can describe unknown repertoires. Petrova GV, Gorski J. Eur J Immunol 42 3001-3008 (2012)
  111. Disease etiology and diagnosis by TCR repertoire analysis goes viral. Attaf M, Sewell AK. Eur J Immunol 46 2516-2519 (2016)
  112. Factors influencing immunodominance hierarchies in TCD8+ -mediated antiviral responses. Irvine K, Bennink J. Expert Rev Clin Immunol 2 135-147 (2006)
  113. HLA-B*27:05 alters immunodominance hierarchy of universal influenza-specific CD8+ T cells. Sant S, Quiñones-Parra SM, Koutsakos M, Grant EJ, Loudovaris T, Mannering SI, Crowe J, van de Sandt CE, Rimmelzwaan GF, Rossjohn J, Gras S, Loh L, Nguyen THO, Kedzierska K. PLoS Pathog 16 e1008714 (2020)
  114. Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8+ T Cells. Pearson JA, Thayer TC, McLaren JE, Ladell K, De Leenheer E, Phillips A, Davies J, Kakabadse D, Miners K, Morgan P, Wen L, Price DA, Wong FS. Diabetes 65 1679-1689 (2016)
  115. The central residues of a T cell receptor sequence motif are key determinants of autoantigen recognition in murine experimental autoimmune encephalomyelitis. Huang JC, Ober RJ, Ward ES. Eur J Immunol 35 299-304 (2005)
  116. Energetic and flexibility properties captured by long molecular dynamics simulations of a membrane-embedded pMHCII-TCR complex. Bello M, Correa-Basurto J. Mol Biosyst 12 1350-1366 (2016)
  117. Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands. Petrich de Marquesini LG, Moustakas AK, Thomas IJ, Wen L, Papadopoulos GK, Wong FS. Eur J Immunol 38 240-249 (2008)
  118. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus. Cukalac T, Moffat JM, Venturi V, Davenport MP, Doherty PC, Turner SJ, Stambas J. Vaccine 27 6755-6761 (2009)
  119. Elucidating the general principles of cell adhesion with a coarse-grained simulation model. Chen J, Xie ZR, Wu Y. Mol Biosyst 12 205-218 (2016)
  120. Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan. van de Sandt CE, Nguyen THO, Gherardin NA, Crawford JC, Samir J, Minervina AA, Pogorelyy MV, Rizzetto S, Szeto C, Kaur J, Ranson N, Sonda S, Harper A, Redmond SJ, McQuilten HA, Menon T, Sant S, Jia X, Pedrina K, Karapanagiotidis T, Cain N, Nicholson S, Chen Z, Lim R, Clemens EB, Eltahla A, La Gruta NL, Crowe J, Lappas M, Rossjohn J, Godfrey DI, Thomas PG, Gras S, Flanagan KL, Luciani F, Kedzierska K. Nat Immunol 24 1890-1907 (2023)
  121. Structure of MHC-Independent TCRs and Their Recognition of Native Antigen CD155. Lu J, Van Laethem F, Saba I, Chu J, Tikhonova AN, Bhattacharya A, Singer A, Sun PD. J Immunol 204 3351-3359 (2020)
  122. Understanding TR binding to pMHC complexes: how does a TR scan many pMHC complexes yet preferentially bind to one. Khan JM, Ranganathan S. PLoS One 6 e17194 (2011)
  123. Biochemical and structural impact of natural polymorphism in the HLA-A3 superfamily. Li L, Bouvier M. Mol Immunol 42 1331-1344 (2005)
  124. Crystal structures of T cell receptor (beta) chains related to rheumatoid arthritis. Li H, Van Vranken S, Zhao Y, Li Z, Guo Y, Eisele L, Li Y. Protein Sci 14 3025-3038 (2005)
  125. Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation. Racape J, Connan F, Hoebeke J, Choppin J, Guillet JG. Proc Natl Acad Sci U S A 103 18208-18213 (2006)
  126. Glimpses at TCR trans-species crossreactivity. Malissen B. Immunity 19 463-464 (2003)
  127. TCR-alpha CDR3 loop audition regulates positive selection. Ferreira C, Furmanski A, Millrain M, Bartok I, Guillaume P, Lees R, Simpson E, MacDonald HR, Dyson J. J Immunol 177 2477-2485 (2006)
  128. Diversity and clonotypic composition of influenza-specific CD8+ TCR repertoires remain unaltered in the absence of Aire. Kedzierska K, Valkenburg SA, Guillonneau C, Hubert FX, Cukalac T, Curtis JM, Stambas J, Scott HS, Kedzierski L, Venturi V, Davenport MP. Eur J Immunol 40 849-858 (2010)
  129. Research Support, Non-U.S. Gov't Immunological techniques: ex vivo characterization of T cell-mediated immune responses in cancer. Speiser DE. Curr Opin Immunol 17 419-422 (2005)
  130. Structural aspect of B*4811 molecule, a novel HLA-B*48 allele identified by sequence-based typing. Kwon OJ, Hwang SH, Heo YS, Hur SS, Oh HB. Tissue Antigens 66 707-709 (2005)
  131. Structural aspects of B*4617 molecule, a novel HLA-B*46 allele identified by sequence-based typing. Sohn YH, Oh HB, Heo YS, Kwon OJ. Tissue Antigens 73 72-74 (2009)
  132. An approach to predicting hematopoietic stem cell transplantation outcome using HLA-mismatch information mapped on protein structure data. Dudkiewicz M, Malanowski P, Czerwin Ski J, Pawłowski K. Biol Blood Marrow Transplant 15 1014-1025 (2009)
  133. Cross-reactivity influences changes in human influenza A virus and Epstein Barr virus specific CD8 memory T cell receptor alpha and beta repertoires between young and old. Clark F, Gil A, Thapa I, Aslan N, Ghersi D, Selin LK. Front Immunol 13 1011935 (2022)
  134. Comment Favorite flavors of surfaces. Jones EY. Nat Immunol 6 365-366 (2005)
  135. Steric recognition of T-cell receptor contact residues is required to map mutant epitopes by immunoinformatical programmes. Hsu SC, Chang CP, Tsai CY, Hsieh SH, Wu-Hsieh BA, Lo YS, Yang JM. Immunology 136 139-152 (2012)
  136. Structural and Biophysical Insights into the TCRαβ Complex in Chickens. Zhang L, Liu Y, Meng G, Liang R, Zhang B, Xia C. iScience 23 101828 (2020)
  137. Thioamide Analogues of MHC I Antigen Peptides. Gibadullin R, Morris RK, Niu J, Sidney J, Sette A, Gellman SH. J Am Chem Soc 145 25559-25569 (2023)
  138. Modified influenza M158-66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge. Lanfermeijer J, van de Ven K, van Dijken H, Hendriks M, Talavera Ormeño CMP, de Heij F, Roholl P, Borghans JAM, van Baarle D, de Jonge J. NPJ Vaccines 8 116 (2023)
  139. Correction of T-Cell Repertoire and Autoimmune Diabetes in NOD Mice by Non-myeloablative T-Cell Depleted Allogeneic HSCT. Sidlik Muskatel R, Nathansohn-Levi B, Reich-Zeliger S, Mark M, Stoler-Barak L, Rosen C, Milman-Krentsis I, Bachar Lustig E, Pete Gale R, Friedman N, Reisner Y. Stem Cells Transl Med 12 281-292 (2023)
  140. Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination. Sabbagh SE, Haribhai D, Gershan JA, Verbsky J, Nocton J, Yassai M, Naumova EN, Hammelev E, Dasgupta M, Yan K, Gorski J, Williams CB. Front Immunol 15 1306490 (2024)
  141. SARS-CoV-2 spike does not interact with the T cell receptor or directly activate T cells. Gaglione SA, Rosales TJ, Schmidt-Hong L, Baker BM, Birnbaum ME. Proc Natl Acad Sci U S A 121 e2406615121 (2024)
  142. Surveillance states. Dash P, Thomas PG. Nat Struct Mol Biol 24 339-341 (2017)


Quick links